• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大麻素系统与神经炎症:对多发性硬化症的影响

Cannabinoid system and neuroinflammation: implications for multiple sclerosis.

作者信息

Correa Fernando, Docagne Fabian, Mestre Leyre, Loría Frida, Hernangómez Miriam, Borrell José, Guaza Carmen

机构信息

Neuroimmunology Group, Functional and Systems Neurobiology Department, Instituto Cajal, Consejo Superior de Investigaciones Científicas, Madrid, Spain.

出版信息

Neuroimmunomodulation. 2007;14(3-4):182-7. doi: 10.1159/000110644. Epub 2007 Dec 5.

DOI:10.1159/000110644
PMID:18073512
Abstract

There is a growing amount of evidence suggesting that cannabinoids may be neuroprotective in central nervous system inflammatory conditions. Advances in the understanding of the physiology and pharmacology of the cannabinoid system have potentiated the interest in cannabinoids as potential therapeutic targets. Here our aim was to update the actions of cannabinoids on immune system and glial cells and their implications on multiple sclerosis. We also show our results on the modulation of cytokines of the IL-12 family by cannabinoids in macrophages and brain microglia. We used murine primary cultures of macrophage and microglia activated by lipopolysaccharide/IFN-gamma and Theiler's virus to study the effects of cannabinoids on the regulation of IL-12 and IL-23 mRNA and protein IL-12p40, evaluated by RT-PCR and ELISA, respectively. Cannabinoids negatively regulate the production of these cytokines by microglial cells in part due to the activation of CB(2) receptors. The effects of cannabinoids on cytokine brain work and on the regulation of neuroinflammatory processes may affect chronic inflammatory demyelinating diseases such as multiple sclerosis.

摘要

越来越多的证据表明,大麻素在中枢神经系统炎症性疾病中可能具有神经保护作用。对大麻素系统生理学和药理学认识的进展增强了人们对大麻素作为潜在治疗靶点的兴趣。在此,我们的目的是更新大麻素对免疫系统和神经胶质细胞的作用及其对多发性硬化症的影响。我们还展示了大麻素对巨噬细胞和脑小胶质细胞中IL-12家族细胞因子的调节作用的研究结果。我们使用经脂多糖/γ干扰素和泰勒氏病毒激活的小鼠巨噬细胞和小胶质细胞原代培养物,分别通过RT-PCR和ELISA评估大麻素对IL-12和IL-23 mRNA以及蛋白IL-12p40表达的调节作用。大麻素通过激活CB(2)受体部分地负向调节小胶质细胞中这些细胞因子的产生。大麻素对细胞因子在脑内的作用以及对神经炎症过程的调节作用可能会影响诸如多发性硬化症等慢性炎症性脱髓鞘疾病。

相似文献

1
Cannabinoid system and neuroinflammation: implications for multiple sclerosis.大麻素系统与神经炎症:对多发性硬化症的影响
Neuroimmunomodulation. 2007;14(3-4):182-7. doi: 10.1159/000110644. Epub 2007 Dec 5.
2
[Cannabinoid system and neuroinflammation:therapeutic perspectives in multiple sclerosis].[大麻素系统与神经炎症:多发性硬化症的治疗前景]
Rev Neurol. 2006;43(9):541-8.
3
Cannabinoid receptors in microglia of the central nervous system: immune functional relevance.中枢神经系统小胶质细胞中的大麻素受体:免疫功能相关性
J Leukoc Biol. 2005 Dec;78(6):1192-7. doi: 10.1189/jlb.0405216. Epub 2005 Oct 4.
4
Study of the regulation of the endocannabinoid system in a virus model of multiple sclerosis reveals a therapeutic effect of palmitoylethanolamide.在多发性硬化症病毒模型中对内源性大麻素系统调节的研究揭示了棕榈酰乙醇胺的治疗作用。
Eur J Neurosci. 2008 Aug;28(4):633-41. doi: 10.1111/j.1460-9568.2008.06377.x. Epub 2008 Jul 24.
5
Cannabinoid influence on cytokine profile in multiple sclerosis.大麻素对多发性硬化症细胞因子谱的影响。
Clin Exp Immunol. 2005 Jun;140(3):580-5. doi: 10.1111/j.1365-2249.2005.02803.x.
6
Cannabinoids ablate release of TNFalpha in rat microglial cells stimulated with lypopolysaccharide.大麻素可消除脂多糖刺激的大鼠小胶质细胞中肿瘤坏死因子α的释放。
Glia. 2003 Jan 15;41(2):161-8. doi: 10.1002/glia.10177.
7
The role of cannabinoid system on immune modulation: therapeutic implications on CNS inflammation.大麻素系统在免疫调节中的作用:对中枢神经系统炎症的治疗意义。
Mini Rev Med Chem. 2005 Jul;5(7):671-5. doi: 10.2174/1389557054368790.
8
Neuroprotective agents: cannabinoids.神经保护剂:大麻素。
Clin Immunol. 2012 Jan;142(1):57-67. doi: 10.1016/j.clim.2011.02.010. Epub 2011 Mar 21.
9
The activation of cannabinoid CB2 receptors stimulates in situ and in vitro beta-amyloid removal by human macrophages.大麻素CB2受体的激活可刺激人体巨噬细胞在原位和体外清除β-淀粉样蛋白。
Brain Res. 2009 Aug 4;1283:148-54. doi: 10.1016/j.brainres.2009.05.098. Epub 2009 Jun 6.
10
The endocannabinoid system as a target for novel anxiolytic and antidepressant drugs.内源性大麻素系统作为新型抗焦虑和抗抑郁药物的靶点。
Int Rev Neurobiol. 2009;85:57-72. doi: 10.1016/S0074-7742(09)85005-8.

引用本文的文献

1
Identification of the Ghrelin and Cannabinoid CB Receptor Heteromer Functionality and Marked Upregulation in Striatal Neurons from Offspring of Mice under a High-Fat Diet.高脂肪饮食下小鼠子代纹状体神经元中 Ghrelin 和大麻素 CB 受体异源二聚体功能的鉴定及明显上调。
Int J Mol Sci. 2021 Aug 19;22(16):8928. doi: 10.3390/ijms22168928.
2
Cannabinoids: A New Perspective on Epileptogenesis and Seizure Treatment in Early Life in Basic and Clinical Studies.大麻素:基础与临床研究中关于早期生命癫痫发生及癫痫治疗的新视角
Front Behav Neurosci. 2021 Jan 12;14:610484. doi: 10.3389/fnbeh.2020.610484. eCollection 2020.
3
Evaluation of the profiles of CB cannabinoid receptor signalling bias using joint kinetic modelling.
使用联合动力学建模评估 CB 大麻素受体信号转导偏倚的特征。
Br J Pharmacol. 2020 Aug;177(15):3449-3463. doi: 10.1111/bph.15066. Epub 2020 May 15.
4
Endocannabinoid Receptors in the CNS: Potential Drug Targets for the Prevention and Treatment of Neurologic and Psychiatric Disorders.中枢内源性大麻素受体:预防和治疗神经和精神疾病的潜在药物靶点。
Curr Neuropharmacol. 2020;18(8):769-787. doi: 10.2174/1570159X18666200217140255.
5
Targeting Cannabinoid Signaling in the Immune System: "High"-ly Exciting Questions, Possibilities, and Challenges.靶向免疫系统中的大麻素信号传导:“高度”令人兴奋的问题、可能性与挑战
Front Immunol. 2017 Nov 10;8:1487. doi: 10.3389/fimmu.2017.01487. eCollection 2017.
6
Real-time characterization of cannabinoid receptor 1 (CB1 ) allosteric modulators reveals novel mechanism of action.大麻素受体1(CB1)变构调节剂的实时表征揭示了新的作用机制。
Br J Pharmacol. 2013 Oct;170(4):893-907. doi: 10.1111/bph.12329.
7
Immunoregulation of a CB2 receptor agonist in a murine model of neuroAIDS.神经艾滋病小鼠模型中 CB2 受体激动剂的免疫调节作用。
J Neuroimmune Pharmacol. 2010 Sep;5(3):456-68. doi: 10.1007/s11481-010-9225-8. Epub 2010 Jun 12.
8
Complementary and alternative medicine for the treatment of multiple sclerosis.补充和替代医学治疗多发性硬化症。
Expert Rev Clin Immunol. 2010 May;6(3):381-95. doi: 10.1586/eci.10.12.
9
Whole plant cannabis extracts in the treatment of spasticity in multiple sclerosis: a systematic review.大麻全植物提取物治疗多发性硬化痉挛:系统评价。
BMC Neurol. 2009 Dec 4;9:59. doi: 10.1186/1471-2377-9-59.
10
Cannabinoids in the management of spasticity associated with multiple sclerosis.大麻素类药物治疗多发性硬化相关痉挛。
Neuropsychiatr Dis Treat. 2008 Oct;4(5):847-53. doi: 10.2147/ndt.s3208.